Novel Diagnosis of Lyme Disease: Potential for CAM Intervention. Issue 3 (2009)

• Record Type: Journal Article
• Authors: Vojdani, Aristo; Hebroni, Frank; Raphael, Yaniv; Erde, Jonathan; Raxlen, Bernard
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 6:Issue 3(2009)
• Page Start: 283
• Page End: 295
• Publication Date: 2009
• Subjects: Borrelia burgdorferi -- in vivo-induced antigen technology -- Lyme disease -- multi-peptide ELISA; Alternative medicine -- Periodicals; 615.505
• DOI: 10.1093/ecam/nem138
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Lyme disease (LD) is the most common tick-borne disease in the northern hemisphere, producing a wide range of disabling effects on multiple human targets, including the skin, the nervous system, the joints and the heart. Insufficient clinical diagnostic methods, the necessity for prompt antibiotic treatment along with the pervasive nature of infection impel the development and establishment of new clinical diagnostic tools with increased accuracy, sensitivity and specificity. The goal of this article is 4-fold: (i) to detail LD infection and pathology, (ii) to review prevalent diagnostic methods, emphasizing inherent problems, (iii) to introduce the usage of in vivo induced antigen technology (IVIAT) in clinical diagnostics and (iv) to underscore the relevance of a novel comprehensive LD diagnostic approach to practitioners of Complementary and Alternative Medicine (CAM). Utilization of this analytical method will increase the accuracy of the diagnostic process and abridge the time to treatment, with antibiotics, herbal medicines and nutritional supplements, resulting in improved quality of care and disease prognosis.